Particularly, Orai3 has emerged as a potential fine‐tuner for Ca2+ signaling in a variety of cancer cells, including breast cancer cells MCF7.[42] Furthermore, several TRP channels were found to have a corporative function with Orai1 in cancer physiology;[43, 44] however, their function during entosis remains unknown. Here, ORAI3 is linked to breast cancer.